Table 2.
The ratio of animals with clinical signs and the mortality after different treatments.
| Treatment | N animals | Animals with clinical sign/treated animals | Died animals/treated animals | |
|---|---|---|---|---|
| Acute toxicity | Negative control | 8 | 0/8 | 0/8 |
| Rh2Cit 107.57 mg/Kg | 8 | 5/8 | 0/8 | |
| Rh2Cit 80.7 mg/Kg | 8 | 6/8 | 0/8 | |
| Rh2Cit 53.8 mg/Kg | 8 | 6/8 | 0/8 | |
| Rh2Cit 26.9 mg/Kg | 8 | 0/8 | 0/8 | |
| Rh2Cit 13.8 mg/Kg | 8 | 1/8 | 0/8 | |
| Subchronic toxicity | Negative control | 6 | 0/6 | 0/6 |
| Rh2Cit 80 mg/Kg | 6 | 0/6 | 0/6 | |
| Rh2Cit 60 mg/Kg | 6 | 0/6 | 0/6 | |
| Rh2Cit 40 mg/Kg | 6 | 0/6 | 0/6 | |
| Rh2Cit 20 mg/Kg | 6 | 0/6 | 0/6 | |
| Rh2Cit 10 mg/Kg | 6 | 0/6 | 0/6 | |
| Paclitaxel 57.80 mg/Kg | 6 | 6/6 | 0/6 | |